Top

Pathology & Oncology Research

Published in:

01-03-2007 | Case Report

Multiple subcutaneous nodular métastases from transitional cell carcinoma of the bladder

Authors: Ali Fuat Atmaca, Ziya Akbulut, Alparslan Demirci, Olcay Belenli, Süleyman Alici, M. Derya Balbay

Published in: Pathology & Oncology Research | Issue 1/2007

Title: Multiple subcutaneous nodular métastases from transitional cell carcinoma of the bladder
Authors: Ali Fuat Atmaca
Ziya Akbulut
Alparslan Demirci
Olcay Belenli
Süleyman Alici
M. Derya Balbay
Publication date: 01-03-2007
Publisher: Springer Netherlands
Published in: Pathology & Oncology Research / Issue 1/2007
Print ISSN: 1219-4956
Electronic ISSN: 1532-2807
DOI: https://doi.org/10.1007/BF02893444

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 1/2007

Prevalence of SLC22A4 1672T and SLC22A5 −207C combination defined TC haplotype in Hungarian ulcerative colitis patients

Sentinel lymph node biopsy in staging small (up to 15 mm) breast carcinomas. Results from a European multi-institutional study

Genomic alterations in low-grade, anaplastic astrocytomas and glioblastomas

Malignancies after renal transplantation during 33 years at a single center

Differential expression of Runx2 and Indian hedgehog in cartilaginous tumors

Association of microvessel density with infiltrating cells in human cutaneous malignant melanoma

Keynote webinar | Spotlight on antibody–drug conjugates in cancer